CNR Institutional Research Information System

DE ROSA, VIVIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 875
NA - Nord America 424
EU - Europa 208
SA - Sud America 135
AF - Africa 9
OC - Oceania 1
Totale 1.652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 397
SG - Singapore 383
HK - Hong Kong 193
CN - Cina 166
BR - Brasile 108
IT - Italia 83
VN - Vietnam 53
NL - Olanda 36
KR - Corea 33
FI - Finlandia 23
DE - Germania 17
CA - Canada 13
FR - Francia 12
MX - Messico 12
AR - Argentina 11
GB - Regno Unito 11
EC - Ecuador 9
BD - Bangladesh 8
IN - India 8
ES - Italia 5
ID - Indonesia 5
RU - Federazione Russa 5
ZA - Sudafrica 5
JO - Giordania 4
JP - Giappone 4
CO - Colombia 3
IE - Irlanda 3
IL - Israele 3
AT - Austria 2
IQ - Iraq 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
UA - Ucraina 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 1.652
Salva come PNG Salva come JPEG
Città #
Singapore 241
Hong Kong 192
Santa Clara 181
Hefei 61
Beijing 55
Naples 43
Seoul 33
Ashburn 32
San Jose 26
Ho Chi Minh City 17
Casandrino 13
Hanoi 13
Los Angeles 13
Helsinki 11
Lappeenranta 11
São Paulo 8
Belleville 6
Chicago 6
Frankfurt am Main 6
New York 6
Boardman 5
Brooklyn 5
Mexico City 5
Dallas 4
Des Moines 4
Düsseldorf 4
Amman 3
Bauru 3
Belo Horizonte 3
Bengaluru 3
Buenos Aires 3
Buffalo 3
Carapicuíba 3
Dublin 3
Guayaquil 3
Lauterbourg 3
Minamishinagawa 3
Poplar 3
Quito 3
Ribeirão Preto 3
Shanghai 3
Atlanta 2
Baghdad 2
Bonito 2
Boston 2
Bratislava 2
Da Nang 2
Falkenstein 2
Ha Long 2
Haiphong 2
Houston 2
Hải Dương 2
Johannesburg 2
Lajeado 2
Milan 2
Minneapolis 2
Moscow 2
Munich 2
Orem 2
Phoenix 2
Phủ Lý 2
Pisa 2
Porto Alegre 2
Praia Grande 2
Quận Chín 2
Rio de Janeiro 2
Rome 2
Sarasota 2
Soccavo 2
Vitória da Conquista 2
Xi'an 2
Abaetetuba 1
Afragola 1
Alenquer Municipality 1
Ambarnath 1
Americana 1
Amparo 1
Amsterdam 1
Aracaju 1
Araucária 1
Astana 1
Athens 1
Aversa 1
Avilés 1
Baalbek 1
Bad Nauheim 1
Baku 1
Bangkok 1
Barquisimeto 1
Barra Mansa 1
Belgrade 1
Benicia 1
Benito Juarez 1
Berehove 1
Bhanga 1
Biên Hòa 1
Blackpool 1
Boca da Mata 1
Bom Jesus dos Perdões 1
Boves 1
Totale 1.135
Salva come PNG Salva come JPEG
Nome #
Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT 65
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 64
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study 61
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 56
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 56
Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib 53
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 53
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors 53
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 51
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 50
Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) 47
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 46
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 45
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art 44
Molecular mechanisms of decreased aerobic glycolysis in non-small lung cancer treated with EGFR tyrosine kinase inhibitors. European Society for Molecular Imaging Meeting 44
18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors 43
A reversible shift of driver dependence from egfr to notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 43
Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC 43
Preclinical imaging for targeting cancer immune evasion 41
Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells 41
Notch1-dependent targets in cancer stem cell resistance to EGFR inhibitors in oncogene-driven non-small cell lung cancer 37
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins 37
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 35
Preclinical Imaging in Targeted Cancer Therapies 35
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 33
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells 33
Early F-18-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 31
Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation. 31
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 28
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 28
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 28
Preclinical imaging in oncology: advances and perspectives 27
Combination of Abeta secretion and oxidative stress in an Alzheimer-like cell line leads to the over-expression of the nucleotide excision repair proteins DDB2 and XPC 25
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 25
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 24
Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? 24
[18]F-FLT PET-CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC. 23
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer. 23
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer 22
18F-FLT PET/CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC 22
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 20
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer 20
18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 19
Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells 19
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC 16
Alzheimer's Disease-Associated Neurotoxic Peptide Amyloid-B Impairs Base Excision Repair in Human Neuroblastoma Cells 15
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 14
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System 11
Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)—A Preliminary In Vitro Study 8
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells 7
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 3
Addition of metformin to anti-PD-1/PD-L1 drugs activates antitumor immune response in peripheral immune cells of NSCLC patients 3
Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells 3
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood 3
Totale 1.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.622
article - articoli 5.142
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 5 8 7 15
2024/2025861 15 14 79 42 195 40 1 58 54 62 156 145
2025/2026835 62 95 73 136 328 90 51 0 0 0 0 0
Totale 1.731